|
⚲
|
| Keyboard |
| Robert Paull | |
|---|---|
| Firm | |
| Address | 490 Arsenal Way Suite 120 Watertown, MA 02472 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc | 021-422740 | Director | 16.1 M of 36.5 M |
||
| Kyruus Inc | 021-310430 | Director | 17.0 M of 24.0 M |
||
| Kyruus Inc | 021-281262 | Director | 4.0 M of 10.0 M |
||
| Kala Pharmaceuticals Inc | 021-261236 | Director | 67.9 M of 67.9 M |
||
| CALA Health Inc | 021-257489 | Director | 18.0 M of 18.0 M |
||
| Kyruus Inc | 021-247873 | Director | 37.0 M of 37.0 M |
||
| Kala Pharmaceuticals Inc | 021-246095 | Director | 7.0 M of 7.0 M |
||
| Kyruus Inc | 021-217689 | Director | 11.2 M of 20.0 M |
||
| Kala Pharmaceuticals Inc | 021-216153 | Director | 22.5 M of 22.5 M |
||
| Genocea Biosciences Inc | 021-204325 | Director | 0.4 M of 0.4 M |
||
| Kala Pharmaceuticals Inc | 021-192576 | Director | 5.8 M of 11.5 M |
||
| Kyruus Inc | 021-189442 | Director | 11.0 M of 11.0 M |
||
| Cerulean Pharma Inc | 021-188408 | Director | 13.0 M of 13.0 M |
||
| Genocea Biosciences Inc | 021-185355 | Director | 30.5 M of 30.5 M |
||
| Kala Pharmaceuticals Inc | 021-174916 | Executive Officer | 7.2 M of 7.2 M |
||
| Cerulean Pharma Inc | 021-170146 | Director | 15.0 M of 15.0 M |
||
| Genocea Biosciences Inc | 021-152851 | Director | 35.1 M of 35.1 M |
||
| Kala Pharmaceuticals Inc | 021-150327 | Executive Officer | 3.0 M of 3.0 M |
||
| Kala Pharmaceuticals Inc | 021-137165 | Executive Officer | 2.0 M of 2.0 M |
||
| Lux Capital Management LLC | |||||
| Lux Ventures Cayman III LP | 021-192331 | Director | 11.3 M of 11.3 M |
1.6 M | |
| Lux Ventures III LP | 021-168729 | Executive Officer | 230.4 M of 230.4 M |
37.8 M | |
| Lux Ventures III Special Founders Fund LP | 021-172544 | Executive Officer | 0.1 M of 0.1 M |
0.0 M | |
| Related People Network |
|---|
| Network #376 at Cerulean Pharma Inc — files alongside 11 co-filers |